NTNX - Jim Cramer Calls This Healthcare Stock A 'Worthy Spec' Recommends Avoiding Canada Goose | Benzinga
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Dutch Bros Inc. (NYSE:BROS).
On May 7, Dutch Bros posted better-than-expected first-quarter financial results and raised its full-year revenue guidance.
“The outlook is fabulous. There is a lawsuit in July that, involving formula,” Cramer said when asked about Abbott Laboratories (NYSE:ABT). “We're waiting until at least it gets to par or 100 to be able to buy more. But we believe in the company.”
On April 17, Abbott Laboratories reported better-than-expected earnings for its first quarter. The company posted first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating ...